167 related articles for article (PubMed ID: 18296570)
1. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction.
Wang HH; Tanaka H; Qin X; Zhao T; Ye LH; Okagaki T; Katayama T; Nakamura A; Ishikawa R; Thatcher SE; Wright GL; Kohama K
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2060-8. PubMed ID: 18296570
[TBL] [Abstract][Full Text] [Related]
2. Nonkinase activity of MLCK in elongated filopodia formation and chemotaxis of vascular smooth muscle cells toward sphingosylphosphorylcholine.
Wang HH; Nakamura A; Matsumoto A; Yoshiyama S; Qin X; Ye LH; Xie C; Zhang Y; Gao Y; Ishikawa R; Kohama K
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1683-93. PubMed ID: 19234090
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin.
Eddinger TJ; Meer DP; Miner AS; Meehl J; Rovner AS; Ratz PH
J Pharmacol Exp Ther; 2007 Feb; 320(2):865-70. PubMed ID: 17132816
[TBL] [Abstract][Full Text] [Related]
4. Blebbistatin inhibits sphingosylphosphorylcholine-induced contraction of collagen-gel fiber populated by vascular smooth-muscle cells.
Katayama T; Yoshiyama S; Tanaka H; Wang HH; Nakamura A; Kohama K
J Pharmacol Sci; 2006 Nov; 102(3):339-42. PubMed ID: 17072099
[TBL] [Abstract][Full Text] [Related]
5. Blebbistatin, a myosin II inhibitor, suppresses contraction and disrupts contractile filaments organization of skinned taenia cecum from guinea pig.
Watanabe M; Yumoto M; Tanaka H; Wang HH; Katayama T; Yoshiyama S; Black J; Thatcher SE; Kohama K
Am J Physiol Cell Physiol; 2010 May; 298(5):C1118-26. PubMed ID: 20164381
[TBL] [Abstract][Full Text] [Related]
6. Specificity of blebbistatin, an inhibitor of myosin II.
Limouze J; Straight AF; Mitchison T; Sellers JR
J Muscle Res Cell Motil; 2004; 25(4-5):337-41. PubMed ID: 15548862
[TBL] [Abstract][Full Text] [Related]
7. Effect of cigarette smoke components on vascular smooth muscle cell migration toward platelet-derived growth factor BB.
Yoshiyama S; Horinouchi T; Miwa S; Wang HH; Kohama K; Nakamura A
J Pharmacol Sci; 2011; 115(4):532-5. PubMed ID: 21422730
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis.
Melton AC; Yee HF
Hepatology; 2007 Jun; 45(6):1446-53. PubMed ID: 17465006
[TBL] [Abstract][Full Text] [Related]
9. The myosin II ATPase inhibitor blebbistatin prevents thrombin-induced inhibition of intercellular calcium wave propagation in corneal endothelial cells.
Ponsaerts R; D'hondt C; Bultynck G; Srinivas SP; Vereecke J; Himpens B
Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4816-27. PubMed ID: 18614806
[TBL] [Abstract][Full Text] [Related]
10. Identification of amino acid substitutions differentiating actin isoforms in their interaction with myosin.
Mossakowska M; Strzelecka-Gołaszewska H
Eur J Biochem; 1985 Dec; 153(2):373-81. PubMed ID: 2934250
[TBL] [Abstract][Full Text] [Related]
11. Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs.
Verhasselt S; Stevens CV; Van den Broecke T; Bracke ME; Roman BI
Bioorg Med Chem Lett; 2017 Jul; 27(13):2986-2989. PubMed ID: 28512027
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo relaxation of corpus cavernosum smooth muscle by the selective myosin II inhibitor, blebbistatin.
Zhang XH; Aydin M; Kuppam D; Melman A; Disanto ME
J Sex Med; 2009 Oct; 6(10):2661-71. PubMed ID: 19686429
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of blebbistatin inhibition of myosin II.
Kovács M; Tóth J; Hetényi C; Málnási-Csizmadia A; Sellers JR
J Biol Chem; 2004 Aug; 279(34):35557-63. PubMed ID: 15205456
[TBL] [Abstract][Full Text] [Related]
14. Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb.
Ramamurthy B; Yengo CM; Straight AF; Mitchison TJ; Sweeney HL
Biochemistry; 2004 Nov; 43(46):14832-9. PubMed ID: 15544354
[TBL] [Abstract][Full Text] [Related]
15. Non-muscle myosin II regulates aortic stiffness through effects on specific focal adhesion proteins and the non-muscle cortical cytoskeleton.
Singh K; Kim AB; Morgan KG
J Cell Mol Med; 2021 Mar; 25(5):2471-2483. PubMed ID: 33547870
[TBL] [Abstract][Full Text] [Related]
16. Cyclic strain induces mouse embryonic stem cell differentiation into vascular smooth muscle cells by activating PDGF receptor beta.
Shimizu N; Yamamoto K; Obi S; Kumagaya S; Masumura T; Shimano Y; Naruse K; Yamashita JK; Igarashi T; Ando J
J Appl Physiol (1985); 2008 Mar; 104(3):766-72. PubMed ID: 18187612
[TBL] [Abstract][Full Text] [Related]
17. Modulation of actin conformation and inhibition of actin filament velocity by calponin.
Borovikov YuS ; Horiuchi KY; Avrova SV; Chacko S
Biochemistry; 1996 Oct; 35(43):13849-57. PubMed ID: 8901528
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells.
Kim TJ; Yun YP
Vascul Pharmacol; 2007 Jan; 46(1):43-51. PubMed ID: 16875883
[TBL] [Abstract][Full Text] [Related]
19. Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1.
Yu JY; Lee JJ; Lim Y; Kim TJ; Jin YR; Sheen YY; Yun YP
J Pharmacol Sci; 2008 May; 107(1):90-8. PubMed ID: 18490856
[TBL] [Abstract][Full Text] [Related]
20. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
Yin H; Gui Y; Zheng XL
J Cell Physiol; 2010 Mar; 222(3):556-64. PubMed ID: 19937728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
